From: "jeffrey E." <[email protected]> To: Boris Nikolic Subject: Re: FMI/Roche standstill Date: Sun, 25 Feb 2018 21:18:46 +0000 i understood that thats why it is better for you to get the cash out now and buy the shares in your own name. too much risk at that high a prcie that bill will fold On Sun, Feb 25, 2018 at 3:57 PM, Boris Nikolic < wrote: Hi! Will call you later today. Please in future, always use this email and not my Hotmail. I am barely using it. You are correct re FMI that I should exercise soon. There are however few upcoming catalysts — next week FDA/CMS final NCD for reimbursement. March 7 — last year final results and projection for 2018. And most importantlyApril 6! April 6 is three years after Roche acquired in tender 58.5% of FMI. Roche will be able to acquire the rest of FMI for the first time after April 6th, Roche just acquired Flatiron Health for 2B https://www.forbes.com/sites/matthewherper/2018/02/15/roche-to-buy-big-data-upstart-flatiron-health-for-1-9- billion/#3d2d610fle85 Flatiron works very closely with FMI. Roche really needs both pieces. FMI genetic data are getting combined with Flatiron clinical data for the full picture. Current FMI share price is $77.65/share If Roche make an acquisition they need to buy the minority of company so it will not cost them that much. There is a rumor of $190-200/share. EFTA00876542